LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS), today announced that it has raised $2.0 million through the sale of newly issued shares of Common Stock and warrants to selected institutional investors. Rodman & Renshaw, LLC served as placement agent for the transaction.
